InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+11.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Frazier Life Sciences Public Fund, L.P.. Insider active across 2 companies, notably Viridian Therapeutics, Inc.\DE. Cumulatively, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €1.9m. History available since 23 September 2021. The latest transaction was filed on 9 December 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Frazier Life Sciences Public Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
4,288,949 股@ US$3.56100.0% 占其流量Common StockSEC:0001231919-25-000588:0
200,000 股@ US$11.00100.0% 占其流量Common StockSEC:0001209191-21-058002:0
标准退出：2021年12月22日 (T+90)
2 条申报中的 2 条
